To include your compound in the COVID-19 Resource Center, submit it here.
ANPI partner Boston Scientific Corp. (BSX, Natick, Mass.) reported final data from the double-blind, international TAXUS II trial of BSX's paclitaxel-eluting stent in which
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury